Bayer (Global Rights of Androcur) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Bayer (Global Rights of Androcur) General Information

Description

Global rights of androcur. The medicine is an anti-androgen therapy. It blocks the actions of male sex hormones (androgens) and reduces the amount of male sex hormones produced by the body. It also serves as a treatment for inoperable carcinoma of the prostate.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Germany
Primary Industry
Buildings and Property
Acquirer
Advanz Pharma
Corporate Office
  • Germany

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bayer (Global Rights of Androcur) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bayer (Global Rights of Androcur)‘s full profile, request access.

Request a free trial

Bayer (Global Rights of Androcur) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bayer (Global Rights of Androcur)‘s full profile, request access.

Request a free trial

Bayer (Global Rights of Androcur) FAQs

  • Where is Bayer (Global Rights of Androcur) headquartered?

    Bayer (Global Rights of Androcur) is headquartered in Germany.

  • What industry is Bayer (Global Rights of Androcur) in?

    Bayer (Global Rights of Androcur)’s primary industry is Buildings and Property.

  • Is Bayer (Global Rights of Androcur) a private or public company?

    Bayer (Global Rights of Androcur) is a Private company.

  • What is Bayer (Global Rights of Androcur)’s current revenue?

    The current revenue for Bayer (Global Rights of Androcur) is .

  • Who are Bayer (Global Rights of Androcur)’s investors?

    Bayer has invested in Bayer (Global Rights of Androcur).

  • When was Bayer (Global Rights of Androcur) acquired?

    Bayer (Global Rights of Androcur) was acquired on 31-Mar-2024.

  • Who acquired Bayer (Global Rights of Androcur)?

    Bayer (Global Rights of Androcur) was acquired by Advanz Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »